71 hits for »medicine shortages«
Sounds of Science – episode 20 Tackling Medicine Shortages: the role of EU Policies Medicine shortages are a growing challenge across Europe, impacting patients, healthcare systems, and companies alike. But how is the EU tackling this issue? What role do EU policies and the upcoming…
…to strengthen the supply of critical medicines in the European Union (EU). Since the publication of the Commission’s Communication on Addressing medicines shortages in the EU, EUCOPE has firmly advocated for a nuanced and holistic approach to address shortages and strengthen supply of medicines in…
…of facing financial penalties for non-compliance with the requirements, and how these would be applied. Furthermore, uncertainties persist regarding the interpretation and implementation of these proposals. Medicine shortages and security of supply The provisions on medicine shortages and notification requirements in case of supply disruptions…
“Getting ahead of Medicine Shortages: the way forward in Europe” Evoke Incisive Health is organising the upcoming breakfast debate ‘Getting Ahead of Medicine Shortages: The Way Forward in Europe’, which will take place on April 26 from 08:30 to 09:30 at Silversquare Europe, Square de…
EUCOPE and its member companies are closely monitoring the COVID-19 situation and its potential impact on the manufacturing and distribution of medicinal products. EUCOPE is reporting any expected shortages or distribution problems due to the COVID-19 outbreak and/or current cross-border restrictions put in place by…
…stakeholders and politicians at both the national and EU level are warning that the MDR is leading to potential medical device shortages, and even medical devices disappearing from the EU market as a whole. In short, the main problem is that under the MDR, all…
In the event the United Kingdom leaves the EU without a deal, access to medicines may be affected and to alleviate any doubts, the EMA has published a questions & answers document on the preparatory work to prevent medicine shortages. If at any point in…
…(HUMN). These concepts risk overlooking patient populations and will have implications on innovation, as well as on market access decisions. EUCOPE urges avoiding unrealistic requirements, especially on medicine shortages and environmental risk assessment (ERA), as recommended by the ENVI committee. Increased administrative barriers will be…
…research and development of innovative and transformative treatments, while improving lives of patients in the EU and globally. EUCOPE underscores the need for a future-proofed regulatory framework, a holistic approach to access policies, support to public-private partnerships, and addressing the root causes of medicine shortages….
…we have a strong and growing pipeline of investigational cancer medicines. One of these investigational medicines is pelabresib. Pelabresib is a novel, orally administered small molecule designed to selectively inhibit the function of BET proteins to decrease the expression of abnormally expressed genes in cancer….
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information